Brind.

Acadia Pharmaceuticals is initiating a Phase 3 study for its drug trofinetide in Japan.

1 report, 0 independent Updated Jun 25
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Acadia Pharmaceuticals is initiating a Phase 3 study for its drug trofinetide in Japan.

Who's involved

What this event is mainly about
Acadia Pharmaceuticals

Keep exploring

The entities involved

  • Acadia Pharmaceuticals

    Pharmaceutical company, which developed Nuplazid, based in San Diego, California.

    Nothing else this week.

Coverage

Newest first; wire copies grouped
  • Unknown outlet